In the August issue of InFocus, Clincierge shares actionable ways to overcome participation barriers for rare diseases. Steps to overcoming participation barriers include coordinating access on a global scale, removing geographic barriers to participation, and leveraging patient coordinators to ensure patient comfort.
Overcoming Participation Barriers for Rare Disease Clinical Trials Read More »
Research teams who appreciate the unique needs of rare disease patients and invest in a white-glove approach on behalf of trial participants can reduce barriers to participation. For sponsors, clinical study teams, and site staff, this means easier patient recruitment at the beginning of a study and fewer dropouts throughout the duration of the trial—with
Reducing Barriers to Participation in Clinical Trials for Rare Disease Read More »
The medical community and cultural opinion agree: clinical trials need diversity. It’s our job to serve affected populations, but we cannot do that if we don’t have an appropriate representation of these populations in our research. Minorities are often more at risk for the disease yet are egregiously underrepresented in clinical trials. Understanding why and
Achieving Clinical Trial Diversity Through Actionable Steps Read More »
Diversity in Clinical Trials: Going Beyond Why to How Diversity is a hot-button issue within the global medical community. The industry continues to seek effective and sustainable solutions to create more diverse clinical trials. Our CEO, Scott Gray, joined Michael Causey, Editor-in-Chief, ACRP TV, to share his insight and practical methods for improving diversity in
Diversity in Clinical Trials: Going Beyond Why to How Read More »
Developing a patient-centric and compliant study is a top priority for any team. Understanding the importance of Institutional Review Boards (IRB) and Ethics Committees (EC) and their role is critical to a successful clinical trial.
